Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-01-30 Purchase |
2023-02-01 4:36 pm |
Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO |
4,444 | $0 | $0 | 26,768 (Direct) |
View |
2020-09-01 Purchase |
2020-09-01 5:48 pm |
Sun BioPharma Inc. | SNBP | Horvath Susan V.P. of Finance & CFO |
2,424 | $0 | $0 | 15,860 (Direct) |
View |
2020-06-05 Purchase |
2020-06-09 6:19 pm |
Sun BioPharma Inc. | SNBP | Horvath Susan V.P. of Finance & CFO |
2,500 | $0 | $0 | 13,512 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-10-01 Option Award |
2024-10-03 4:26 pm |
N/A 2034-10-01 |
Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO |
25,480 | $0 | 25,480 (Direct) |
View |
2023-03-27 Option Award |
2023-03-29 4:25 pm |
N/A 2033-03-27 |
Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO |
34,369 | $0 | 34,369 (Direct) |
View |
2021-09-13 Option Award |
2021-09-15 5:59 pm |
N/A 2031-09-13 |
Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO |
12,135 | $0 | 12,135 (Direct) |
View |
2021-03-30 Option Award |
2021-04-01 09:33 am |
N/A 2031-03-30 |
Panbela Therapeutics Inc. | PBLA | Horvath Susan V.P. of Finance & CFO |
40,000 | $0 | 40,000 (Direct) |
View |
2020-06-24 Option Award |
2020-06-26 4:50 pm |
N/A 2030-06-24 |
Sun BioPharma Inc. | SNBP | Horvath Susan V.P. of Finance & CFO |
32,000 | $0 | 32,000 (Direct) |
View |